Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleEXPERT COMMENTARY ON THE PRODUCT PROFILE OF Belzutifan for Renal Cell Carcinoma.AuthorsKhrystolubova, NatashaSubjectsRENAL cell carcinoma; PHARMACOGENOMICS; VON Hippel-Lindau disease; TREATMENT effectiveness; PHARMACEUTICAL services insurance; ENZYME inhibitors; DRUG toxicity; PHARMACODYNAMICSPublicationOncology (08909091), 2022, Vol 36, Issue 1, p64ISSN0890-9091Publication typeArticle